MiR-200b/200c/429 subfamily negatively regulates Rho/ ROCK signaling pathway to suppress hepatocellular carcinoma metastasis

Oncotarget

Volumn 6, Issue 15, 2015, Pages 13658-13670

  Wong, Chun Ming ^a   Wei, Lai ^a   Au, Sandy Leung Kuen ^a   Fan, Dorothy Ngo Yin ^a   Zhou, Yuan ^b   Tsang, Felice Ho Ching ^a   Law, Cheuk Ting ^a   Lee, Joyce Man Fong ^a   He, Xianghuo ^c   Shi, Jue ^b   Wong, Carmen Chak Lui ^a   Ng, Irene Oi Lin ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cancer metastasis; Cytoskeletal reorganization; Hepatocellular carcinoma; mir 200 family; RHO ROCK signaling pathway

Indexed keywords

MICRORNA; MICRORNA 141; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 429; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE 2; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG; MIRN200 MICRORNA, HUMAN; MIRN429 MICRORNA, HUMAN; RHOA PROTEIN, HUMAN; ROCK2 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; FOCAL ADHESION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; MOUSE MODEL; NONHUMAN; STRESS FIBER; ANIMAL; BAGG ALBINO MOUSE; CELL GROWTH; GENETICS; HEP-G2 CELL LINE; LIVER TUMOR; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL GROWTH PROCESSES; CELL LINE, TUMOR; HEP G2 CELLS; HETEROGRAFTS; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84931075204     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3700     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90.
2. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136:215-233.
3. Gao P, Wong CC, Tung EK, Lee JM, Wong CM and Ng IO. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J Hepatol. 2011; 54:1177-1184.
4. Wong CM, Wong CC, Lee JM, Fan DN, Au SL and Ng IO. Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis. Hepatology. 2012; 55:1453-1461.
5. Park SM, Gaur AB, Lengyel E and Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008; 22:894-907.
6. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10(5):593-601.
7. Korpal M, Lee ES, Hu G and Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008; 283(22):14910-14914.
8. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S and Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008; 9:582-589.
9. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF and Goodall GJ. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008; 68:7846-7854.
10. Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T and Si J. Downregulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol. 2009; 44:556-561.
11. Wiklund ED, Bramsen JB, Hulf T, Dyrskjot L, Ramanathan R, Hansen TB, Villadsen SB, Gao S, Ostenfeld MS, Borre M, Peter ME, Orntoft TF, Kjems J and Clark SJ. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer. 2011; 128:1327-1334.
12. Zidar N, Bostjancic E, Gale N, Kojc N, Poljak M, Glavac D and Cardesa A. Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck--hallmark of epithelial-mesenchymal transition. Hum Pathol. 2011; 42:482-488.
13. Li A, Omura N, Hong SM, Vincent A, Walter K, Griffith M, Borges M and Goggins M. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res. 2010; 70:5226-5237.
14. Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E, Wellner U, Dimmler A, Faller G, Schubert J and Brabletz T. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 2011; 30:770-782.
15. Brabletz S and Brabletz T. The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer? EMBO Rep. 2010; 11:670-677.
16. Gaidatzis D, van Nimwegen E, Hausser J and Zavolan M. Inference of miRNA targets using evolutionary conservation and pathway analysis. BMC Bioinformatics. 2007; 8:69.
17. Wong CC, Wong CM, Tung EK, Au SL, Lee JM, Poon RT, Man K and Ng IO. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology. 2011; 140:322-331.
18. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T and Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006; 25:2537-2545.
19. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology. 2008; 47:1955-1963.
20. Dhayat SA, Mardin WA, Kohler G, Bahde R, Vowinkel T, Wolters H, Senninger N, Haier J and Mees ST. The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma? Journal of surgical oncology. 2014.
21. Ebert MS and Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012; 149:515-524.
22. Kaibuchi K, Kuroda S and Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem. 1999; 68:459-486.
23. Sahai E and Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer. 2002; 2:133-142.
24. Wong CM, Lee JM, Ching YP, Jin DY and Ng IO. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res. 2003; 63:7646-7651.
25. Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY and Ng IO. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J Biol Chem. 2003; 278:10824-10830.
26. Wong CC, Wong CM, Ko FC, Chan LK, Ching YP, Yam JW and Ng IO. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma. PLoS One. 2008; 3:e2779.
27. Wong CC, Wong CM, Tung EK, Man K and Ng IO. Rhokinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology. 2009; 49:1583-1594.
28. Lewis BP, Burge CB and Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120:15-20.
29. John B, Enright AJ, Aravin A, Tuschl T, Sander C and Marks DS. Human MicroRNA targets. PLoS Biol. 2004; 2:e363.